Alpha Tau Medical (DRTS) EBIT (2021 - 2026)
Alpha Tau Medical (DRTS) posted EBIT of $13.3 million for Q1 2026, up 5.64% sequentially from $12.6 million in Q4 2025, and up 43.03% YoY from $9.3 million in Q1 2025.
Alpha Tau Medical (DRTS) EBIT (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported EBIT for 6 years, with the latest figure at $13.3 million in Q1 2026.
- Quarterly EBIT rose 43.03% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 25.37% YoY) and the FY2025 annual result came in at $42.3 million, up 17.33% from the prior year.
- EBIT climbed to $13.3 million in Q1 2026 per DRTS's latest filing, from $12.6 million in the prior quarter.
- Over five years, EBIT peaked at $13.3 million in Q1 2026 and troughed at $7.4 million in Q3 2022.
- A 5-year average of $9.4 million and a median of $8.9 million in 2023 frame the typical range for EBIT.
- The sharpest annual moves came in 2022 and 2024: EBIT jumped 221.06% in 2022, then decreased 7.11% in 2024.
- Over 5 years, EBIT stood at $8.0 million in 2022, then grew by 24.52% to $9.9 million in 2023, then advanced by 3.33% to $10.3 million in 2024, then increased by 22.66% to $12.6 million in 2025, then climbed by 5.64% to $13.3 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered $13.3 million, $12.6 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -40.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.41 Mn |
| Mar 31, 2026 | 13.31 Mn |
| Dec 31, 2025 | 12.60 Mn |
| Sep 30, 2025 | 10.73 Mn |
| Jun 30, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.31 Mn |
| Dec 31, 2024 | 10.27 Mn |
| Sep 30, 2024 | 8.29 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Mar 31, 2024 | 8.42 Mn |
| Dec 31, 2023 | 9.94 Mn |
| Sep 30, 2023 | 8.93 Mn |
| Jun 30, 2023 | 8.17 Mn |
| Mar 31, 2023 | 8.64 Mn |
| Dec 31, 2022 | 7.99 Mn |
| Sep 30, 2022 | 7.36 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 8.78 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.63 Mn |